SCHEMBL7546276

SCHEMBL7546276

Cc1ccccc1CC(=O)c1ccnc(N)c1C(=O)Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
SHBG P04278 2/20 0.44
CNR2 P34972 2/20 0.37
NR3C2 P08235 2/20 0.37
CTBP2 P56545 1/20 0.37
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ANO1 Q5XXA6 1/20 0.36
MAPK8 P45983 1/20 0.36
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
CTNNB1 P35222 1/20 0.35
WNT3A P56704 1/20 0.35
NPC1 O15118 1/20 0.34
P2RX7 Q99572 1/20 0.34
CACNA1G O43497 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7547894 0.88 MAPT (0.46) MEN1MAPTKMT2ASHBGCNR2
SCHEMBL8799386 0.86 SHBG (0.44) MEN1KMT2ASHBGCNR2CTBP2
SCHEMBL9059987 0.83 SGMS2 (0.35) MEN1MAPTKMT2ASHBGNR3C2
SCHEMBL7548395 0.81 ALOX5 (0.38) NPC1
SCHEMBL7600813 0.80
SCHEMBL7548471 0.79 MAPK13 (0.41) ALDH1A1NOS3NOS1NOS2CTNNB1
SCHEMBL7546252 0.79 TDP1 (0.32) NOS3NOS2
SCHEMBL7546196 0.78 KDM4E (0.38) KDM4ENOS3NOS2NPC1
SCHEMBL9063741 0.76 NPC1 (0.39) ALDH1A1NOS3NOS1NOS2CTNNB1
SCHEMBL8805065 0.75 SHBG (0.44) MEN1KMT2ASHBGCNR2CTBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997049708-A9 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS 1998-05-22 WO disclosed
EP-0811008-A1 BICYCLIC BENZAZEPINE DERIVATIVES AS VASOPRESSIN ANTAGONISTS American Cyanamid Company (US) 1997-12-10 EP disclosed